Dymon Asia Capital (Singapore)’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
Other funds holding MDT
FWIA
GAM
SRIM
DC
Dymon Asia Capital (Singapore)'s MDT Position: Q2 2026 in Review
Dymon Asia Capital (Singapore) increased its Medtronic (MDT) stake by 153% in Q2 2026, buying an estimated $3.08M and bringing the position to 63,130 shares worth $4.94M. The position accounts for 0.21% of the portfolio, ranked #69.
Dymon Asia Capital (Singapore) first reported a position in MDT in Q1 2025 and has held it in 3 quarters since. 959 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- Dymon Asia Capital (Singapore) held 63,130 shares of Medtronic worth $4.94M as of Q2 2026.
- Dymon Asia Capital (Singapore) bought 38,130 Medtronic shares in Q2 2026, an estimated $3.08M.
- Medtronic made up 0.21% of Dymon Asia Capital (Singapore)'s portfolio in Q2 2026, its #69 holding.
- Dymon Asia Capital (Singapore) first reported a position in Medtronic in Q1 2025 and has held it in 3 quarters since.
- 959 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on Dymon Asia Capital (Singapore)'s 13F filing for Q2 2026, filed 23 Jul 2026.